IN2014DN08394A - - Google Patents

Info

Publication number
IN2014DN08394A
IN2014DN08394A IN8394DEN2014A IN2014DN08394A IN 2014DN08394 A IN2014DN08394 A IN 2014DN08394A IN 8394DEN2014 A IN8394DEN2014 A IN 8394DEN2014A IN 2014DN08394 A IN2014DN08394 A IN 2014DN08394A
Authority
IN
India
Prior art keywords
cell responses
hiv
pathogen
toggle
cytokines
Prior art date
Application number
Other languages
English (en)
Inventor
Riol Marta Ruiz
Christian Brander
Javier Ibarrondo
Original Assignee
Esteve Labor Dr
Fundació Privada Inst De Recerca De La Sida Caixa
Institució Catalana De Recerca I Estudis Avançats
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr, Fundació Privada Inst De Recerca De La Sida Caixa, Institució Catalana De Recerca I Estudis Avançats filed Critical Esteve Labor Dr
Publication of IN2014DN08394A publication Critical patent/IN2014DN08394A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866—Interferon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/525—Tumor necrosis factor [TNF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN8394DEN2014 2012-03-23 2013-03-22 IN2014DN08394A (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615038P 2012-03-23 2012-03-23
EP12382109 2012-03-23
PCT/EP2013/056110 WO2013139972A1 (en) 2012-03-23 2013-03-22 Method for monitoring hiv specific t cell responses

Publications (1)

Publication Number Publication Date
IN2014DN08394A true IN2014DN08394A (de) 2015-05-08

Family

ID=49221879

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8394DEN2014 IN2014DN08394A (de) 2012-03-23 2013-03-22

Country Status (9)

Country Link
US (1) US9709577B2 (de)
EP (1) EP2828656B1 (de)
JP (1) JP6272820B2 (de)
CN (1) CN104272108A (de)
CA (1) CA2868066C (de)
HK (1) HK1205264A1 (de)
IN (1) IN2014DN08394A (de)
MX (1) MX2014011484A (de)
WO (1) WO2013139972A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101777256B1 (ko) 2016-07-07 2017-09-12 대한민국(농림축산식품부 농림축산검역본부장) T 세포의 병원체 감염 세포 독성능 평가 방법
KR101777252B1 (ko) 2016-07-07 2017-09-12 대한민국(농림축산식품부 농림축산검역본부장) T 세포의 prrsv 증식 억제능 평가 방법
CN110308285B (zh) * 2019-07-12 2022-07-26 中国人民解放军军事科学院军事医学研究院 用于预测重度电离辐射损伤死亡的标志物组合
CA3255609A1 (en) * 2022-03-09 2023-09-14 Institucio Catalana De Recerca I Estudis Avanqats AMPLIFIED IMMUNE MONITORING METHODS FOR ANALYZING ANTIGEN-SPECIFIC T LYMPHOCYTE RESPONSES
CN115754303A (zh) * 2022-11-24 2023-03-07 复旦大学附属华山医院 基于Th1和Th2细胞因子组合的评价方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9624456D0 (en) * 1996-11-25 1997-01-15 Isis Innovation Assay method
US6656471B1 (en) * 1998-11-17 2003-12-02 Board Of Regents, The University Of Texas System HIV-specific T-cell induction
AU2002952548A0 (en) * 2002-11-08 2002-11-21 Cellestis Limited Diagnostic assay
US7323346B2 (en) * 2003-08-14 2008-01-29 The General Hospital Corporation Screening for gestational disorders
EP1767937A1 (de) * 2005-09-27 2007-03-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Verfahren zur Diagnose von tuberkulosebedingtem Immunrekonstitutionssyndrom (IRS)
ES2349338T3 (es) * 2006-03-20 2010-12-30 St Vincent's Hospital Sydney Limited Un método para detectar células t activadas por mitógenos o específicas de antígeno.
WO2008127840A2 (en) * 2007-03-22 2008-10-23 University Of Iowa Research Foundation Flavivirus ns5a proteins for the treatment of hiv
US20090263828A1 (en) * 2008-04-16 2009-10-22 Franco Lori Novel assay for precursor T-cells having high proliferative capacity (PHPC-asay)
WO2010037408A1 (en) * 2008-09-30 2010-04-08 Curevac Gmbh Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
MX374963B (es) * 2011-04-29 2025-03-06 Selecta Biosciences Inc Nanoportadores sintéticos tolerogénicos para reducir las respuestas de anticuerpos.

Also Published As

Publication number Publication date
HK1205264A1 (en) 2015-12-11
CA2868066C (en) 2019-11-12
US9709577B2 (en) 2017-07-18
CN104272108A (zh) 2015-01-07
WO2013139972A1 (en) 2013-09-26
US20150057175A1 (en) 2015-02-26
EP2828656A1 (de) 2015-01-28
EP2828656B1 (de) 2019-09-18
JP2015513100A (ja) 2015-04-30
CA2868066A1 (en) 2013-09-26
JP6272820B2 (ja) 2018-01-31
MX2014011484A (es) 2015-09-23

Similar Documents

Publication Publication Date Title
MX2018004206A (es) Metodos para diagnosticar enfermedades infecciosas utilizando medios de adsorcion.
IN2014DN08394A (de)
PH12018500558B1 (en) Device and system for analyzing a sample, particularly blood, as well as methods of using the same
WO2013130274A3 (en) Aluminum alloy with additions of scandium, zirconium and erbium
EP2825298A4 (de) Mischungen aus sulfonierten blockcopolymeren sowie teilchenförmiger kohlenstoff und membranen, folien und beschichtungen damit
EP4410315A3 (de) Anti-cd3-antikörper und verfahren zur verwendung
EP2775162A3 (de) Verbundstoffwulstplatte und Luftfeder damit
EP3522570A3 (de) Raumklangsignalfilterung
WO2015175301A8 (en) Flexible, integrated urine-based diagnostic device
CL2017001043A1 (es) Detección de malaria.
IN2015DN01760A (de)
EP2927046A3 (de) Schutzsystem gegen verkehrtes anschliessen von batterien
EP2557407A3 (de) Drucksensor
EP3293254A3 (de) Assays am pflegeort zum nachweis des zustands einer tuberkuloseinfektion
WO2018162740A3 (en) Cell culture supplements
WO2016069612A3 (en) Biomarkers for early diagnosis and differentiation of mycobacterial infection
WO2016029094A8 (en) Specimen conditioning and imaging system
WO2014153661A8 (en) Method for detecting and monitoring bone loss
EP2623842A3 (de) Keilringabdichtung
RU2011153126A (ru) Способ видовой идентификации микобактерий туберкулеза у лиц, инфицированных микобактериями туберкулеза
EP2624408A3 (de) Verfahren und Systeme zur Steuerung einer Ladevorrichtung
WO2016168741A8 (en) Detection of human cytomegalovirus
RU2014152102A (ru) Способ оценки состояния здоровья человека при прогнозировании течения инфекционного заболевания
EP2657827A3 (de) Berührungserkennungsverfahren und Berührungssteuerungsvorrichtung damit
EP2738100A3 (de) Flugzeug mit Sicherheitsanalysezone